FIELD: medicine.
SUBSTANCE: method involves applying intracoronary phosphocreatine introduction into infarction-responsible artery when carrying out coronary angioplasty. Phosphocreatine solution is injected after reperfusing the infarction-responsible artery at constant volume rate of 0.1-4 ml/s with introduced phosphocreatine dose being equal to 0.5-4 g.
EFFECT: reduced myocardium necrosis zone; prevented cardiac insufficiency and cardiac rhythm disorders.
4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION | 2005 |
|
RU2299730C1 |
| METHOD OF TREATMENT OF ACUTE MYOCARDIAL INFARCTION | 2006 |
|
RU2343921C2 |
| METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENT WITH MYOCARDIUM ISCHEMIA IN CORONARY-INVASIVE OPERATIONS | 1999 |
|
RU2146933C1 |
| METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
| METHOD OF ACUTE MYOCARDIAL INFARCTION TREATMENT | 2008 |
|
RU2365380C1 |
| METHOD FOR APPLYING REPERFUSION THERAPY TO ACUTE MYOCARDIAL INFARCTION PATIENTS | 2002 |
|
RU2226097C2 |
| METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
| WATER-SOLUBLE COMPOSITION, POSSESSIVE PROPERTIES OF CARDIO-PROTECTOR | 2010 |
|
RU2438698C1 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| METHOD FOR ENDOVASCULAR CORRECTION OF NO-REFLOW PHENOMENON IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION OF CULPRIT ARTERY | 2014 |
|
RU2574123C1 |
